Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - New York Stock Exchange, Inc. - US09260D1072 - Common Stock - Currency: USD

142.96  +2.98 (+2.13%)

After market: 142 -0.96 (-0.67%)

Fundamental Rating

5

Taking everything into account, BX scores 5 out of 10 in our fundamental rating. BX was compared to 232 industry peers in the Capital Markets industry. BX has an excellent profitability rating, but there are concerns on its financial health. BX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BX was profitable.
BX had a positive operating cash flow in the past year.
BX had positive earnings in each of the past 5 years.
In the past 5 years BX always reported a positive cash flow from operatings.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

The Return On Assets of BX (5.62%) is better than 71.98% of its industry peers.
Looking at the Return On Equity, with a value of 31.89%, BX belongs to the top of the industry, outperforming 95.69% of the companies in the same industry.
BX's Return On Invested Capital of 16.42% is amongst the best of the industry. BX outperforms 90.95% of its industry peers.
BX had an Average Return On Invested Capital over the past 3 years of 12.81%. This is above the industry average of 7.88%.
The 3 year average ROIC (12.81%) for BX is below the current ROIC(16.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROIC 16.42%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

BX's Profit Margin of 19.83% is fine compared to the rest of the industry. BX outperforms 60.34% of its industry peers.
BX's Profit Margin has declined in the last couple of years.
The Operating Margin of BX (49.58%) is better than 86.21% of its industry peers.
In the last couple of years the Operating Margin of BX has remained more or less at the same level.
Industry RankSector Rank
OM 49.58%
PM (TTM) 19.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BX has been increased compared to 1 year ago.
The number of shares outstanding for BX has been increased compared to 5 years ago.
The debt/assets ratio for BX has been reduced compared to a year ago.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

BX has an Altman-Z score of 3.45. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BX (3.45) is better than 78.45% of its industry peers.
BX has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as BX would need 3.48 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.48, BX is doing good in the industry, outperforming 72.84% of the companies in the same industry.
BX has a Debt/Equity ratio of 1.56. This is a high value indicating a heavy dependency on external financing.
BX has a worse Debt to Equity ratio (1.56) than 74.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Altman-Z 3.45
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
BX's Current ratio of 0.71 is on the low side compared to the rest of the industry. BX is outperformed by 68.53% of its industry peers.
A Quick Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
BX's Quick ratio of 0.71 is on the low side compared to the rest of the industry. BX is outperformed by 68.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.95% over the past year.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.97% yearly.
Looking at the last year, BX shows a very strong growth in Revenue. The Revenue has grown by 24.23%.
The Revenue has been growing by 12.51% on average over the past years. This is quite good.
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%

3.2 Future

BX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.53% yearly.
BX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.92% yearly.
EPS Next Y7.48%
EPS Next 2Y19.17%
EPS Next 3Y21.17%
EPS Next 5Y12.53%
Revenue Next Year6.31%
Revenue Next 2Y17.04%
Revenue Next 3Y19.15%
Revenue Next 5Y15.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.10, BX can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BX is valued a bit more expensive than the industry average as 71.98% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.59. BX is around the same levels.
The Price/Forward Earnings ratio is 21.70, which indicates a rather expensive current valuation of BX.
BX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.39. BX is around the same levels.
Industry RankSector Rank
PE 30.1
Fwd PE 21.7
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BX is valued a bit cheaper than the industry average as 64.22% of the companies are valued more expensively.
BX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 48.47
EV/EBITDA 28.53
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BX does not grow enough to justify the current Price/Earnings ratio.
BX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 21.17% in the coming years.
PEG (NY)4.02
PEG (5Y)2.01
EPS Next 2Y19.17%
EPS Next 3Y21.17%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.94%, BX has a reasonable but not impressive dividend return.
BX's Dividend Yield is comparable with the industry average which is at 8.22.
BX's Dividend Yield is a higher than the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 2.94%

5.2 History

On average, the dividend of BX grows each year by 11.16%, which is quite nice.
BX has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BX decreased recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

200.72% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP200.72%
EPS Next 2Y19.17%
EPS Next 3Y21.17%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (6/10/2025, 8:04:01 PM)

After market: 142 -0.96 (-0.67%)

142.96

+2.98 (+2.13%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-17 2025-04-17/bmo
Earnings (Next)07-16 2025-07-16/amc
Inst Owners70.58%
Inst Owner Change0.01%
Ins Owners0.77%
Ins Owner Change8.96%
Market Cap173.44B
Analysts75.63
Price Target154.9 (8.35%)
Short Float %1.82%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 2.94%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP200.72%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-28 2025-04-28 (0.93)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)0.65%
Max EPS beat(2)12.43%
EPS beat(4)3
Avg EPS beat(4)3.56%
Min EPS beat(4)-5.35%
Max EPS beat(4)12.43%
EPS beat(8)4
Avg EPS beat(8)1.84%
EPS beat(12)7
Avg EPS beat(12)2.31%
EPS beat(16)11
Avg EPS beat(16)8.06%
Revenue beat(2)1
Avg Revenue beat(2)2.32%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)4.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)4.86%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)1
Avg Revenue beat(12)-21.14%
Revenue beat(16)5
Avg Revenue beat(16)18.31%
PT rev (1m)1.88%
PT rev (3m)-19.3%
EPS NQ rev (1m)0.53%
EPS NQ rev (3m)-18.35%
EPS NY rev (1m)-5.06%
EPS NY rev (3m)-14.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.28%
Valuation
Industry RankSector Rank
PE 30.1
Fwd PE 21.7
P/S 13.52
P/FCF 48.47
P/OCF 47.51
P/B 21.74
P/tB 29.24
EV/EBITDA 28.53
EPS(TTM)4.75
EY3.32%
EPS(NY)6.59
Fwd EY4.61%
FCF(TTM)2.95
FCFY2.06%
OCF(TTM)3.01
OCFY2.11%
SpS10.58
BVpS6.58
TBVpS4.89
PEG (NY)4.02
PEG (5Y)2.01
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROCE 19.68%
ROIC 16.42%
ROICexc 18.35%
ROICexgc 19.92%
OM 49.58%
PM (TTM) 19.83%
GM N/A
FCFM 27.89%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Debt/EBITDA 1.95
Cap/Depr 202.82%
Cap/Sales 0.57%
Interest Coverage 14.9
Cash Conversion 57.07%
Profit Quality 140.65%
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z 3.45
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
EPS Next Y7.48%
EPS Next 2Y19.17%
EPS Next 3Y21.17%
EPS Next 5Y12.53%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%
Revenue Next Year6.31%
Revenue Next 2Y17.04%
Revenue Next 3Y19.15%
Revenue Next 5Y15.92%
EBIT growth 1Y22.76%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year5.28%
EBIT Next 3Y18.21%
EBIT Next 5Y6.22%
FCF growth 1Y-3.07%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-7.35%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%